Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOCILIZUMAB Cause Systemic lupus erythematosus? 8,656 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 8,656 reports of Systemic lupus erythematosus have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 8.8% of all adverse event reports for TOCILIZUMAB.

8,656
Reports of Systemic lupus erythematosus with TOCILIZUMAB
8.8%
of all TOCILIZUMAB reports
1,965
Deaths
2,552
Hospitalizations

How Dangerous Is Systemic lupus erythematosus From TOCILIZUMAB?

Of the 8,656 reports, 1,965 (22.7%) resulted in death, 2,552 (29.5%) required hospitalization, and 2,118 (24.5%) were considered life-threatening.

Is Systemic lupus erythematosus Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 8,656 reports have been filed with the FAERS database.

What Other Side Effects Does TOCILIZUMAB Cause?

Drug ineffective (32,342) Rheumatoid arthritis (20,652) Pain (18,384) Off label use (18,256) Arthralgia (15,536) Joint swelling (14,831) Fatigue (13,802) Rash (12,327) Drug intolerance (11,952) Contraindicated product administered (11,547)

What Other Drugs Cause Systemic lupus erythematosus?

ADALIMUMAB (11,880) METHOTREXATE (9,350) INFLIXIMAB (9,071) ABATACEPT (8,944) HYDROXYCHLOROQUINE (8,867) RITUXIMAB (8,819) PREDNISONE (8,799) LEFLUNOMIDE (8,669) FOLIC ACID (8,360) CERTOLIZUMAB PEGOL (8,212)

Which TOCILIZUMAB Alternatives Have Lower Systemic lupus erythematosus Risk?

TOCILIZUMAB vs TOCILIZUMAB-AAZG TOCILIZUMAB vs TOCOPHEROL TOCILIZUMAB vs TOFACITINIB TOCILIZUMAB vs TOFERSEN TOCILIZUMAB vs TOLNAFTATE

Related Pages

TOCILIZUMAB Full Profile All Systemic lupus erythematosus Reports All Drugs Causing Systemic lupus erythematosus TOCILIZUMAB Demographics